The 24.16x EV/EBITDA premium of roughly five turns over both AMT and SBAC appears difficult to attribute to superior earnings quality, particularly when reported revenue has contracted to about $1.0B from $1.6B pre-divestiture. Negative P/FFO prints across the last five quarters (-8.04 in 2026Q3) are arithmetic artifacts of impairment-distorted FFO, so investors should anchor instead on an implied cap rate using the restored tower-only NOI run-rate. If the market is applying a pre-divestiture cash flow multiple to a substantially smaller asset base, the valuation may already discount a recovery that the -5.5% FFO growth rate does not yet evidence.

The restoration of NOI margin to the 73-74% range seen through 2025 is consistent with shedding lower-margin fiber and small cell operations, implying the remaining macro towers carry structurally better incremental economics. However, FFO per share of $1.09 in 2026Q3 sits below the $1.12 of 2025Q3 despite the higher margin, which may indicate that share count, retained leverage, or interest burden is absorbing the margin gain. Investors should test whether same-store tenant billings growth, rather than the divestiture itself, is now the source of any NOI improvement.

A payout ratio approaching 100% of FFO, paired with an AFFO payout exceeding 100% in 2026Q1 (146.4% on FFO) and again on an AFFO basis, suggests distributions have been sustained by capital sources beyond recurring operations rather than by cushion within them. The improvement from the 146.4% peak appears partly attributable to the reduced quarterly dividend rather than stronger AFFO generation, so the safety margin should be judged against the new, lower distribution, not the historical one. With AFFO per share of $0.93 versus $1.02 in 2025Q3, investors should monitor whether the raised full-year 2026 AFFO guidance converts into actual per-share coverage in subsequent quarters.

The recovery in interest coverage from 1.93x to 2.63x appears to reflect both higher operating income on the tower-only base and the reduction of total debt from $29.6B, which is a meaningful improvement in servicing capacity. Even so, debt-to-gross-assets is the only credible leverage read here, since debt-to-equity of 5.60 last printed in 2024Q3 and cannot be recomputed with negative equity; on a gross-asset basis, $22.9B against roughly $20.6B of total assets implies liabilities still exceed the asset base. With cash of just $133.0M at 2026Q3 against that debt stack, refinancing capacity and covenant headroom warrant close attention given the REIT's rate sensitivity.

Crown Castle's US-only concentration removes the international currency and emerging-market risk carried by AMT and SBAC, which could rationally support a narrower discount rate, yet that same concentration concentrates exposure to three carrier capex budgets in a way its peers' diversified revenue does not. The 5.5% headline yield versus AMT's 3.6% and SBAC's 2.4% is likely read by the market as a leverage and coverage discount rather than a valuation bargain, consistent with a balance sheet where equity has been fully impaired. Uniti's 9.75x EV/EBITDA shows how heavily the sector penalizes a distressed capital structure, and investors should consider whether CCI's multiple sits closer to the tower cohort or to that stressed comp as coverage data develops.